SC 13G Filing

Company

GYRE THERAPEUTICS, INC.

Filed

April 19, 2017

Accession Number

0001214659-17-002617

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →